AI assistant
ETHZilla Corp — Director's Dealing 2021
Dec 10, 2021
33039_dirs_2021-12-10_f299169c-1952-403f-a653-955867eee9c3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: 180 Life Sciences Corp. (ATNF)
CIK: 0001690080
Period of Report: 2021-12-08
Reporting Person: STEINMAN LAWRENCE (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-09 | Common Stock | P | 5000 | $4.27 | Acquired | 602574 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-12-08 | Stock Option (Right to Buy) | $3.95 | A | 25000 | Acquired | 2031-12-08 | Common Stock (25000) | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $4.24 to $4.28. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
F2: Granted to the Reporting Person pursuant to the Issuer's 2020 Omnibus Incentive Plan in consideration for services to be rendered. Exempt from Section 16(b) of the Securities Exchange Act of 1934 under Rule 16b-3.